ClinicalTrials.gg
Not yet recruitingNCT07369245TAC-ADDICTUpdated Apr 16, 2026

Techniques for Activating Consciousness (TAC) for Outpatients With Moderate to Severe Alcohol Addiction

An interventional study of TAC intervention in Alcohol Addiction, sponsored by Versailles Hospital. Not yet recruiting at 2 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-04-16.

Sponsored by Versailles Hospital · Not applicable, Interventional, and Supportive care

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
98
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 94 studies in Alcoholism with a site in France — 24 open to participants now, 25 under way, 1 of them phase 3. Alcoholism · France.

Planned enrollment
40th of 58
98 · median 153
Started
2026
with 7 others
No phase
42 of 94
15 open now
Primary completion
2027-07
later than 11 of 24 live
Registered
89th of 94
by date

Among the 94 studies in Alcoholism with a site in France, this one is the 40th largest by planned enrollment of the 58 interventional ones that give a count, is one of 8 that started in 2026, is one of 42 with no phase, reaches primary completion later than 11 of the 24 other live ones, and was the 89th registered.

Alcoholism

1,679 studies on the registry are indexed under Alcoholism; 333 are open to participants now.

Browse Alcoholism studies →

Open to participants now

24 of the 94 studies in Alcoholism with a site in France are open now. Recruiting first, the newest first:

19 more — sign in →

All 24 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 238 Alcoholism studies recruiting now, 85 (36%) set no upper age limit and 131 (55%) stop at 75 or younger; 9 take children under 18; 64 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 94 studies in Alcoholism with a site in France, or all of them as a file.
02

Study summary

Many patients are considering the use of so-called "hypnosis" treatments in the field of addictions. However, these techniques lack sufficient levels of evidence with regard to the standards required by Evidence-Based Medicine.

In other domains, however, hypnosis has demonstrated an interesting level of evidence, particularly in pain management.

The investigators will focus on the "Techniques for Activating Consciousness" (TAC), which represent an optimized therapeutic approach derived from hypnotic therapy.

03

Conditions studied

  • Alcohol Addiction

Browse trials for

Keywords

  • Hypnotic therapy
  • Techniques for Activating Consciousness (TAC)
  • Alcohol addiction
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patients consulting for an alcohol-related addiction problem at the CSAPA of Versailles (sites in Versailles, Trappes, Rambouillet) or at the Centre Hospitalier des 4 Villes (day hospital or CSAPA in Sèvres)
  • Patients must meet at least 4 of the 11 criteria (Annex 2), corresponding to moderate to severe addiction
  • Patients must be affiliated with the French social security system

Exclusion criteria

Exclusion Criteria:

  • Refusal to participate
  • Decompensated psychiatric pathology contraindicating therapy:

    • Presence at inclusion of delusional, dissociative, and/or persecutory symptoms
    • Presence at inclusion of hypomanic or manic decompensation
  • Severe cognitive impairment, evidenced by inability to perform the clock-drawing test (draw the clock face, place the numbers, and set the hands to 11:10)
  • Adults legally protected under French law (deprivation of liberty, legal safeguard, guardianship, curatorship)
  • Inability to understand French
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
98 participants (estimated)

Study arms

  • No intervention
    Control
  • Experimental
    TAC intervention

    Behavioral: TAC intervention

Interventions

  • BehavioralTAC intervention

    Patients receiving TAC (Techniques for Activating Consciousness) intervention in addition to standard care

06

What researchers measure

Primary outcomes

  1. The patient's ability to control alcohol consumption during outpatient follow-up in a CSAPA

    The main outcome measure will be the number of weeks to achieve the targeted goal between T0 (first consultation when the objective is set) and M6 (cumulative time).

    Time frame: 6 months

Secondary outcomes

  1. Controlling addictive behavior in both groups

    Evaluation criteria for both groups: * Cumulative time over 12 months during which the subject meets the target of controlling addictive behavior; percentage of time at target between T0-M6 and T0-M12; number of weeks to reach the target; number of relapses between T0-M6 and T0-M12; time between achieving the target and relapse between T0-M12 * Craving intensity (weekly via electronic patient questionnaire) * Levels of anxiety and depression (HAD scale) and global relaxation (IERS-3), at T0, M6, and M12 * Care received (interventions, medications) from medical records at M6 and M12 * Patient opinion questionnaire at M6 and M12 on what was perceived as useful or not in their treatment

    Time frame: 12 months

  2. Evaluation criteria for the TAC group

    Weekly self-reports (via electronic patient questionnaire) on the frequency of exercise practice, perceived effectiveness of TAC (Techniques for Activating Consciousness) on their addictive issues (VAS 0-10), and tolerance of TAC (Techniques for Activating Consciousness)

    Time frame: 12 months

07

Study locations

2 sites
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Apr 2026; primary completion for Jul 2027, 15 months later.

Of 472 non-industry interventional studies with no phase under Alcoholism, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 54. This study's planned 15 months is below that.

Counting every sponsor, half of 495 studies reached it within 33 months; a quarter within 17 and three quarters within 52.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 30, 2025
First posted
Jan 27, 2026
StartEst.
Apr 15, 2026
Primary completionEst.
Jul 15, 2027
CompletionEst.
Jan 15, 2028
Last update
Apr 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07369245
Lead sponsor
Versailles Hospital
Responsible party
Dr Claire FARINA (Investigator Coordonnator, Versailles Hospital) — Principal investigator
First posted
Jan 27, 2026
Start date
Apr 15, 2026 (estimated)
Primary completion
Jul 15, 2027 (estimated)
Completion
Jan 15, 2028 (estimated)
Last update
Apr 16, 2026

Study contacts

Claire FARINA, Dr
Contact
cfarina@ght78sud.fr
01 39 63 93 80 ext. +33
Nadia YOUNES, Dr
Contact
nyounes@ght78sud.fr

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion